Advances in Therapy is an international, peer reviewed, rapid-publication journal dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research in clinical medicine across all therapeutic areas. Studies relating to diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.
Advances in Therapy is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research and reviews. The journal appeals to a global audience and receives submissions from all over the world.
Moving forward from traditional publishing, Advances in Therapy offers a range of additional features designed to increase visibility and readership. Each paper is accompanied by a bulleted slide summary, giving a time-efficient overview of the content to a wider readership. Articles also have the option to include slide sets, videos, animations, and/or interactive learning resources. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.
Please note: Advances in Therapy's open access articles are published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/2.5.
Upon acceptance of your article for publication, you will be required to pay the article processing charge of £420/€510/$650 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.
For more information about the journal, please contact firstname.lastname@example.org or see the News page for the latest journal offers.